| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 60.6 | 46.9 | 29.6 |
| Other income | 1.7 | 0.5 | 5.2 |
| Total income | 62.4 | 47.4 | 34.8 |
| Profit before exceptional items & tax | 5.1 | 2.1 | 2.5 |
| Profit before tax | 5.1 | 2.1 | 2.5 |
| Net profit | 4.4 | 1.6 | 1.9 |
| Operating margin | 8.2% | 4.4% | 7.2% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +131.60% |
|---|---|
| Net profit, quarter on quarter | +175.00% |
| Revenue, year on year | +104.70% |
BSE results filing, NSE: MEDICAMEQ. Figures extracted from the filing.
Medicamen Biotech Ltd: key numbers
- Share price
- ₹315.30
- Market cap
- ₹427.7 Cr
- Revenue (annual)
- ₹197.8 Cr
- Net profit (annual)
- ₹9.64 Cr
- P/E (TTM)
- 39.5×Sector 50.4×
- Promoter holding
- 40.46%+0.00% QoQ
- FII holding
- 0.07%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Medicamen Biotech Ltd
All →Medicamen Biotech Annual General Meeting
Medicamen Biotech Limited held its 33rd Annual General Meeting on September 26, 2026. The meeting concluded after discussing standard business and special resolutions.
Medicamen Biotech Annual General Meeting
Medicamen Biotech Limited filed its notice for the 33rd Annual General Meeting scheduled for September 26, 2026, alongside the Integrated Annual Report for FY 2025-26.
Medicamen Biotech Q1 FY27 Results: Net Profit ₹184.6 Cr, Up 15.3% YoY
Medicamen Biotech Ltd reported revenue from operations of ₹4,790 Cr (+11.3% YoY) and net profit of ₹184.6 Cr (+15.3% YoY) for Q1 FY27.
- Key figure
- Net profit ₹184.6 Cr · +15.3% YoY
Medicamen Biotech Q1 FY27 Results: Net Profit ₹1.8 Cr, Up 12.5% YoY
Medicamen Biotech Ltd reported revenue from operations of ₹47.9 Cr (+11.4% YoY) and net profit of ₹1.8 Cr (+12.5% YoY) for Q1 FY27.
- Key figure
- Net profit ₹1.8 Cr · +12.5% YoY